In this Issue
The Future Is Now
Guest Chief Medical Editors’ Page
By Bart Dolmatch, MD, FSIR; and Monnie Wasse, MD, MPH, FASN
A multidisciplinary discussion on patient selection, achieving proficiency, procedural tips, and the importance of collaboration.
With John E. Aruny, MD; William C. Jennings, MD, FACS; Charmaine E. Lok, MD; and Aris Urbanes, MD
A status overview of six major clinical trials evaluating the use of covered stents in AV access treatment.
By Bart Dolmatch, MD, FSIR; and Ziv Haskal, MD, FSIR, FAHA, FACR, FCIRSE
An overview of anatomic and patient considerations in cephalic arch stenosis and our approach to managing this complication for dialysis access.
By Andrew Wigham, BSc, MBBS, FRCR; and James Gilbert, BM BS, MA(Ed), FRCS
Clinical presentation, anatomic patterns of TCVO, and revascularization strategies.
By Brian Holly, MD; and Mark L. Lessne, MD
Key investigators discuss the impact of the JAHA mortality and safety meta-analysis and what it means for ongoing studies, follow-up protocols, informed consent, and more.
With Panagiotis M. Kitrou, MD, MSc, PhD, EBIR; Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; and Scott O. Trerotola, MD
The impact that current CMS reimbursement has had on the settings for dialysis access care and a look ahead at the forthcoming rate decisions.
By Terry Litchfield, MPA
Society meetings, live conferences, simulated training, and online resources are invaluable tools for patient-centered and value-based care.
By Therese A. Wykoff, MS; Gerald Beathard, MD, PhD; Ingemar Davidson, MD, PhD; Bart Dolmatch, MD, FSIR; Maurizio Gallieni, MD; Nicholas Inston, MD, PhD; Ngoh Chin Liew, MD; Richard F. Neville, MD, FACS; Billy Nolen, Captain; John Ross, MD; and Douglas Slakey, MD
ONLINE EXCLUSIVE FEATURED TECHNOLOGYSponsored by Boston Scientific Corporation
Ongoing clinical studies will shed light on patient outcomes in real-world settings.
By Ian T. Meredith, MBBS, PhD, AM
MEDICAL AFFAIRS CORNERSponsored by Medtronic
By Prabir Roy-Chaudhury, MD, PhD
Dr. Ullery discusses his approach to challenging EVAR scenarios, improving post-EVAR surveillance, and thoughts on the current CLI landscape.